IBD studies measuring antibody responses following SARS-CoV-2 vaccination have corroborated our findings in patients with anti-TNF therapy after two or three vaccine doses [10,11,12,17,18,19,23,24,25,26]. The gene discussed is TNF; the disease is inflammatory bowel disease.